Ransomware Group: AKIRA

VICTIM NAME: Anfarm Hellas

NOTE: No files or stolen information are [exfiltrated/downloaded/taken/hosted/seen/reposted/disclosed] by RedPacket Security. Any legal issues relating to the content of the files should be directed at the attackers directly, not RedPacket Security. This blog is simply posting an editorial news post informing that a company has fallen victim to a ransomware attack. RedPacket Security is in no way affiliated or aligned with any ransomware threat actors or groups and will not host infringing content. The information on this page is fully automated and redacted whilst being scraped directly from the AKIRA Onion Dark Web Tor Blog page.

AI Generated Summary of the Ransomware Leak Page

The ransomware leak involves Anfarm Hellas, a pharmaceutical company based in Greece that manufactures generic medications for human use. The compromised data, which amounts to over 35 gigabytes, includes sensitive corporate documents such as contact information for government agencies in several countries, detailed financial records, corporate non-disclosure agreements, and personal employee data. The attack occurred on April 16, 2025, and the leak was publicly announced later that day. The leaked data presents significant risks, particularly given the inclusion of government contact details and confidential financial information, which could be exploited for further malicious activities.

The stolen data appears to cover multiple operational aspects of Anfarm Hellas, including confidential company reports, audit files, payment information, and employee personal data. The leak also involves client information, potentially compromising business relationships. The leak page includes minimal visual material, with no screenshot or specific images provided, but references to extensive documents that could cause substantial disruption if misused. No direct links to download the data are available on the leak page, but the disclosure indicates significant vulnerabilities within the company’s cybersecurity defenses. The incident underlines the importance of robust data security protocols for organizations handling sensitive health and financial information in the pharmaceutical sector.